Are anti-inflammatory therapies viable treatments for psychiatric disorders? Where the rubber meets the road

JAMA Psychiatry

Volumn 72, Issue 6, 2015, Pages 527-528

  Miller, Andrew H ^a   Raison, Charles L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CELECOXIB; INTERLEUKIN 1; INTERLEUKIN 6; MINOCYCLINE; NEUROTRANSMITTER; TUMOR NECROSIS FACTOR;

CROHN DISEASE; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; GENE EXPRESSION; GENETIC RISK; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MENTAL DISEASE; NOTE; PATHOPHYSIOLOGY; RISK ASSESSMENT; SCHIZOPHRENIA; TREATMENT RESPONSE; ULCERATIVE COLITIS; MENTAL DISORDERS;

ANTI-INFLAMMATORY AGENTS; HUMANS; MENTAL DISORDERS;

EID: 84931060145     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.22     Document Type: Note

References (7)

1. Haroon E, Raison CL, Miller AH. Psychoneuroim-munology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137-162.
2. Köhler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014;71(12):1381-1391.
3. Insel TR, Gogtay N. National Institute of Mental Health clinical trials: new opportunities, new expectations. JAMA Psychiatry. 2014;71(7):745-746.
4. Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31-41.
5. Uher R, Tansey KE, Dew T, et al. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry. 2014;171(12):1278-1286.
6. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25(2):181-213.
7. Manabe T, Togashi H, Uchida N, et al. Loss of cadherin-11 adhesion receptor enhances plastic changes in hippocampal synapses and modifies behavioral responses. Mol Cell Neurosci. 2000;15(6):534-546.